Sotera Health Co (SHC) reported adjusted earnings of 26 cents per share for the quarter ended September 30, surpassing last year’s 17 cents and beating the mean analyst expectation of 22 cents. Wall Street had forecast EPS in the range of 21 to 22 cents.

Revenue rose 9.1% year-over-year to $311.31 million, exceeding analysts’ estimate of $303.63 million. The company posted a quarterly net income of $48.4 million.

Sotera Health shares gained 5.6% during the quarter and are up 21.4% year-to-date. Analysts currently maintain an average rating of “buy,” with 5 recommending “strong buy” or “buy” and 3 recommending “hold.” There are no “sell” ratings.

The median 12-month price target for Sotera Health is $16.85, slightly above its last closing price of $16.61.